Why Pick Xeomin?

Xeomin is the first treatment that does not require refrigeration before use, which aids in simplifing distribution. Xeomin also has no additives, just botulinum toxin type A. This means that there is less risk of developing antibodies against Xeomin than other available neurotoxins. The body develops antibodies in response to a foreign invader and attacks it. If this happens, the antibodies could prevent a neurotoxin from working. Similar to Botox, the effects of Xeomin occur within one week, and last from three to six months.


84,000 people have been treated with Xeomin injections worldwide. The U.S. being the 20th country to approve this new drug.